Latest / Decera Clinical Education Oncology Podcast
The Latest Evidence on Targeting B7-H3 in Small Cell Lung Cancer
In this episode, hear Lauren Byers, MD and Christine Hann, MD share their insights on the latest data regarding new therapies targeting B7-H3 in small cell lung cancer including:
Rationale for targeting B7-H3
Overview of the structure of antibody-drug conjugates (ADCs)
Results from the phase I/II IDeate-PanTumor01 trial of ifinatamab deruxtecan (I-DXd) in ES-SCLC
Data from the phase II IDeate-Lung02 trial of 2 different doses of I-DXd in patients with previously treated ES-SCLC
An overview of the ongoing phase III trials IDeate-Lung02 and IDeate-Lung03 of I-DXd in SCLC
Early phase evidence on…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.